# Rowasa

NDC: 0037-0066
Generic name: mesalamine
Labeler / Manufacturer: Viatris Specialty LLC
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: SUSPENSION
Routes: RECTAL
Marketing started: 20160324

FDA application: NDA019618

## Active ingredients

- MESALAMINE: 4 g/60mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0037-0066"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0037-0066
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=e505ab99-1943-4216-a178-4d5dbe64e3b2